Geneva-based SGS, a global specialist in testing, inspection and certification, has signed an agreement to acquire IEC (Institut d'Expertise Clinique).
A French family-owned group founded in 1990, IEC conducts clinical trials to assess safety and efficacy, as well as to test the effectiveness of its products. in vitrosensory analysis studies, as well as consumer tests. These tests are carried out for dermatological and ophthalmological products in the cosmetics, pharmaceutical and chemical sectors. The group - which employs over 150 people - is present in Europe, Asia and Africa, serving an international clientele of some of the world's most prestigious brands.
Completion of the acquisition remains subject to the usual conditions precedent, including employee consultation in France.
"Joining SGS, a leader in our sector, is a fantastic opportunity for IEC. It will help us to better serve our customers by leveraging the many synergies offered by such a global player, whether in terms of innovation, marketing, operational excellence or international expansion. We look forward to joining such a powerful network.said IEC Chairman Etienne Camel.
"We are delighted to welcome IEC and its talented teams to SGS. This acquisition is aligned with our strategic objectives and further strengthens our global leadership in cosmetics and hygiene testing. IEC brings SGS innovative capabilities and strong scientific expertise, as well as a complementary geographic footprint and service offering."said Géraldine Picaud, CEO of SGS.
SGS is a multi-sector group with almost 100,000 employees and a network of over 2,600 offices and laboratories worldwide.
